BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 17924862)

  • 1. Interactions between microvascular and macrovascular disease in diabetes: pathophysiology and therapeutic implications.
    Krentz AJ; Clough G; Byrne CD
    Diabetes Obes Metab; 2007 Nov; 9(6):781-91. PubMed ID: 17924862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased prevalence of microvascular complications in type 2 diabetes patients with the metabolic syndrome.
    Abdul-Ghani M; Nawaf G; Nawaf F; Itzhak B; Minuchin O; Vardi P
    Isr Med Assoc J; 2006 Jun; 8(6):378-82. PubMed ID: 16833164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concomitant macro and microvascular complications in diabetic nephropathy.
    Alwakeel JS; Al-Suwaida A; Isnani AC; Al-Harbi A; Alam A
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):402-9. PubMed ID: 19414942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes-associated macrovasculopathy: pathophysiology and pathogenesis.
    Rahman S; Rahman T; Ismail AA; Rashid AR
    Diabetes Obes Metab; 2007 Nov; 9(6):767-80. PubMed ID: 17924861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 2 diabetes mellitus: prevention of macrovascular complications.
    Meeuwisse-Pasterkamp SH; van der Klauw MM; Wolffenbuttel BH
    Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):323-41. PubMed ID: 18327994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of advanced glycation end products (AGEs) and their receptor (RAGE) in the pathogenesis of diabetic microangiopathy.
    Yamagishi S; Takeuchi M; Inagaki Y; Nakamura K; Imaizumi T
    Int J Clin Pharmacol Res; 2003; 23(4):129-34. PubMed ID: 15224502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complications of type 1 diabetes.
    Melendez-Ramirez LY; Richards RJ; Cefalu WT
    Endocrinol Metab Clin North Am; 2010 Sep; 39(3):625-40. PubMed ID: 20723824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular disease in the metabolic syndrome: do we need to target the microcirculation to treat large vessel disease?
    Krentz AJ; Clough G; Byrne CD
    J Vasc Res; 2009; 46(6):515-26. PubMed ID: 19571572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of disease: Pathway-selective insulin resistance and microvascular complications of diabetes.
    Groop PH; Forsblom C; Thomas MC
    Nat Clin Pract Endocrinol Metab; 2005 Dec; 1(2):100-10. PubMed ID: 16929378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving microvascular outcomes in patients with diabetes through management of hypertension.
    McGill JB
    Postgrad Med; 2009 Mar; 121(2):89-101. PubMed ID: 19332966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cigarette smoking and diabetes.
    Eliasson B
    Prog Cardiovasc Dis; 2003; 45(5):405-13. PubMed ID: 12704597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic microvascular complications: can patients at risk be identified? A review.
    Girach A; Manner D; Porta M
    Int J Clin Pract; 2006 Nov; 60(11):1471-83. PubMed ID: 17073842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of angiopathies in type 2 diabetes mellitus--results of a prospective 10 year study].
    Lundershausen R; Zabel-Langhennig R; Pissarek D; Panzram G
    Z Gesamte Inn Med; 1988 Dec; 43(23):658-62. PubMed ID: 3245247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing cardiovascular complications of type 2 diabetes by targeting multiple risk factors.
    Reasner CA
    J Cardiovasc Pharmacol; 2008 Aug; 52(2):136-44. PubMed ID: 18670366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microvascular and macrovascular complications in diabetic nephropathy patients referred to nephrology clinic.
    Al-Wakeel JS; Hammad D; Al Suwaida A; Mitwalli AH; Memon NA; Sulimani F
    Saudi J Kidney Dis Transpl; 2009 Jan; 20(1):77-85. PubMed ID: 19112222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex differences in micro- and macro-vascular complications of diabetes mellitus.
    Maric-Bilkan C
    Clin Sci (Lond); 2017 May; 131(9):833-846. PubMed ID: 28424377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Arterial hypertension in diabetes mellitus].
    Tiengo A
    G Clin Med; 1990 Jan; 71(1):3-6, 10-6. PubMed ID: 2142112
    [No Abstract]   [Full Text] [Related]  

  • 18. Sialic Acid, possible marker of angiopathic complications at diabetics type 2.
    Faur L; Motocu M; Moldovan C; Onaca M; MuĊ£iu G
    Rom J Morphol Embryol; 2005; 46(4):307-9. PubMed ID: 16688368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypertension in patients with diabetes mellitus].
    Okubo K; Kiyohara Y
    Nihon Rinsho; 2003 Jul; 61(7):1081-6. PubMed ID: 12877066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Late complications of diabetes mellitus type II (non-insulin- dependent)].
    Czech A
    Pol Tyg Lek; 1993 Apr; 48 Suppl 1():23-8. PubMed ID: 8516200
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.